Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection.
Curtiss
D
D
School of Pharmacy (DC), Division of Gastroenterology, Creighton University, Omaha, NE, USA.
Kaufman
S
S
Harrison
C J
CJ
D002644:Chickenpox / Q000517:prevention & control*; D006509:Hepatitis B / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007223:Infant; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins